INVESTIGATING THE ROLE OF NF-κB, COX-1, COX-2, COMT, IL-10, IL-6 AND TNF-α IN MODULATING ANTI-NOCICEPTIVE ACTIVITY OF METHANOLIC EXTRACT OF ENTADA PHASEOLOIDES by BARUA, CHANDANA CHOUDHURY et al.
Barua et al. 





INVESTIGATING THE ROLE OF NF-κB, COX-1, COX-2, COMT, IL-10, IL-6 AND TNF-α IN 
MODULATING ANTI-NOCICEPTIVE ACTIVITY OF METHANOLIC EXTRACT OF ENTADA 
PHASEOLOIDES 
 
CHANDANA CHOUDHURY BARUAa*, S. M. ABDUL AZIZ BARBHUIYAa, LIPIKA BURAGOHAINa, AJAY KAKATIa, 
ACHEENTA GOHAIN BARUAb 
aDepartment of Pharmacology and Toxicology, College of Veterinary Science, Assam Agricultural University, Guwahati, Assam 781022, 
India, bDepartment of Veterinary Public Health, College of Veterinary Science, Assam Agricultural University, Guwahati, Assam 781022, 
India 
Email: chanacin@gmail.com 
Received: 14 May 2020, Revised and Accepted: 27 Jun 2020 
ABSTRACT 
Objective: To investigate the analgesic activity of methanolic extract of Entada phaseoloides (MEEP) along with its molecular mechanistic pathway. 
Methods: Swiss albino female mice and Wistar rats of either sex were administered orally with MEEP extracts (100, 200 and 400 mg/kg) and 
pentazocine, tramadol and diclofenac sodium, as standard drugs. Following administration, anti-nociceptive activity was evaluated using an acetic 
acid-induced writhing test, Eddy’s hot plate, and hot water immersion test. Serum was collected for molecular expression of various proteins and 
genes using Reverse Transcriptase PCR and Western Blotting. 
Results: Acetic acid writhing test, a frequently used method to assess peripheral analgesic activity, revealed that MEEP reduced peripherally 
induced pain in a dose-dependent manner. Likewise, Eddy’s hot plate and hot water immersion methods, often implicated for testing central 
analgesic activities, showed that MEEP is bestowed with the capability to counteract analgesia in a dose and time-dependent manner. Pro-
inflammatory cytokines and factors like COX-2, IL-6, TNF-α, and NF-κB that cause inflammatory responses and pain were significantly reduced, 
suggesting its analgesic and anti-inflammatory potential. This analgesic and the anti-inflammatory role played by MEEP is also supported by the up-
regulation of anti-inflammatory cytokine IL-10 and COMT and COX-1 enzyme demonstrated no significant difference between the groups.  
Conclusion: The study revealed the weak peripheral and potent central analgesic property MEEP by modulating pro-inflammatory and anti-
inflammatory pathways. 
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INTRODUCTION 
Entada phaseoloides , commonly known as box bean or St. Thomas’ 
bean, has got multifarious healing properties against various 
ailments. Locally known as Gila (Sanskrit), Gila bean (English) or 
Hathibij (Hindi), etc. [1]. It is taxonomically placed in Leguminosae 
family of genus Entada. This plant had been mentioned in Chinese 
historical materials viz., "Nanfang Caomu Zhuang" and "Bencao 
Gangmu" [2]. Especially, the stems and seeds are important in 
conventional Chinese remedy for their effectiveness against various 
diseases. Seeds (Ketengzi) are used to treat haemorrhoids, 
constipation, and stomach-ache, while the stems (Guoganglong) are 
well known for treating rheumatoid arthritis, tetraplegia, and 
traumatic injury [3, 4]. This plant is popular and renowned amid 
many communities for its significant folkloric uses. The decoctions 
of dried vine materials are effective in treating rheumatic lumbar, 
leg pains, sprain, and contusions; powdered seeds were taken with 
water for malnutrition-related jaundice and edema, for relief from 
abdominal pain, a poultice of pound kernel seed is topically applied 
onto the affected area for colic and seed paste were used as counter-
irritant to cure glandular swellings in the axilla, loins, and joints. 
South African community uses the seed to bite on during the 
‘teething period’ in infants. Customarily, this plant has been used to 
cure cerebral hemorrhage, skin itches, vomiting, etc. [5]. The plant 
also reported having anthelmintic, aphrodisiac [6], anti-
inflammatory [7], anti-diabetic [8], and anti-tumor activity [9]. In the 
North-Eastern part of India, the paste of the bark is used as an ulcer 
protective agent [10]. Our previous investigations elucidated the 
anti-depressant, memory-enhancing [11] and stress relieving [12] 
activities of methanolic extract of Entada phaseoloides (MEEP). 
Different studies have unveiled the presence of various 
phytoconstituents, such as phenylacetic acid derivatives [13], sulfur-
containing amides [14, 15], oleanane-type triterpene saponins [16, 
17] in this plant. 
Pain is a remarkable indication of inflammation, which is unduly 
stressful. Pain is generally treated with NSAIDs, opioids, and non-opioids 
analgesics, which have many undesired side effects. For the management 
of acute pain in clinical use, opioid analgesics are generally used as they 
have maximal analgesic potency [18-20]. Hence, as an alternative 
remedy, folkloric and traditional medicinal plants are tried; however, 
scientific validation of many such plants are still incomplete. The efficacy 
of the seeds of Entada Phaseoloides as a topical analgesic [21] and anti-
inflammatory [22] agent has already been reported by others. The anti-
nociceptive effect of Entada phaseoloides seeds formulation after topical 
application in arthritic wistar rats [22] and analgesic activity of seed 
kernel extracts and methanolic extract of Entada phaseoloides Merrill 
[23] are reported. 
However, the underlying molecular mechanism of its analgesic 
property is not yet reported. The present study is undertaken to 
evaluate the analgesic activity of MEEP and an attempt to investigate 
the role of various pro and anti-inflammatory factors involved in its 
anti-nociceptive activity. 
MATERIALS AND METHODS 
Pentazocine (an opioid narcotic analgesic), tramadol (a narcotic-like 
analgesic), and diclofenac sodium (Non-steroidal anti-inflammatory 
drug) were procured from Themis Medicare Ltd. (Uttarkhand India), 
Alkem Laboratories Ltd. (Sikkim, India) and Cadila Pharmaceuticals 
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Ltd. (Gujarat, India) respectively. All other chemicals used were of 
analytical grade. All the primary antibodies (NFκB and IL-10) used 
for western blotting assay were procured from Santa Cruz 
Technology (Danvers, MA), while the primers (COX-1, COX-2, TNF-α, 
COMT and IL-6) used for Reverse transcriptase PCR were obtained 
from Imperial Life Science Pvt. Ltd. (Haryana, India). 
Animals 
Thirty numbers of healthy Swiss albino female mice (25-30 gm) and 
thirty numbers of wistar rats (150-220 gm) of either sex were 
obtained from the animal house of the Department of Veterinary 
Pharmacology and Toxicology, College of Veterinary Science, 
Khanapara. The experimental protocol had been approved by the 
Institutional Animal Ethics Committee (IAEC) of the College of 
Veterinary Sciences, Assam Agricultural University, Khanapara (Ref 
no. 770/ac/CPCSEA/FVSc, AAU/IAEC/15-16/367). The experimental 
animals were maintained under standard laboratory conditions 
(12:12 h light/dark cycle) at ambient temperature (22-25 °C) and kept 
in polypropylene cages with free access to standard balanced ration, 
clean drinking water ad libitum. 
Plant collection and identification 
The dried seeds of Entada phaseoloides purchased from the local 
market of Sonapur during the month of April-May, 2016, were 
identified by taxonomist Dr. Iswar Chandra Barua, Principal 
Scientist, Department of Agronomy, Assam Agricultural University, 
Jorhat, Assam; a voucher specimen (AAU-NW-EVM-3) was deposited 
and kept at the herbarium of the Department of Agronomy, Assam 
Agricultural University, Jorhat-785013, Assam. 
Preparation of methanolic extract 
After collection, the kernel of the seeds was properly removed and 
dried under shade. The seeds were then finely ground to powder, 
weighed, and stored in an airtight container away from sunlight. 
Then, 250 gm of powdered seed was soaked in 1000 ml of methanol 
for 72 h was stirred after every 18 h with the help of a sterile glass 
rod. The mixture was then subjected to filtration (with the help of 
Whatman filter paper no. 1) and the solvent was removed using a 
rotary evaporator (BUCHI, R-210, Labortechnik AG, 
Meierseggstrasse Switzerland) under reduced pressure, leaving 
behind a dark brown residue (MEEP). The Extract so obtained is 
stored in an airtight container at 4 °C. The percentage yield of the 
methanolic extract was 10.11% (w/w).  
Acute toxicity studies 
Acute toxicity studies were conducted in Swiss albino mice (20-30g) 
following the Organization of Economic Corporation Development 
(OECD) Guidelines No. 423. The extracts were administered orally to a 
group of mice (n=3) at the dose rate of 2000 mg/kg and the 
percentage mortality, if any, was recorded. For the next 14 d, animals 
were kept under observation to check if any abnormality or mortality 
occurred. Based on the results of the acute toxicity study, doses of 100, 
200, and 400 mg/kg were chosen for carrying out the study. 
Peripheral analgesic activity study 
Acetic acid-induced writhing 
The peripheral antinociceptive activity of MEEP was determined in 
female mice by the acetic acid-induced writhing test. Five groups 
(n=6) were taken for the study. Group 1 received distilled water orally 
and served as control. Group 2 received diclofenac sodium (10 mg/kg 
body weight i. p.), served as a standard group [24]. Group 3, 4, and 5 
served as test groups and received MEEP (100, 200, and 400 mg/kg 
body weight, p. o., respectively). The writhes were induced by the 
intraperitoneal injection of 0.6% acetic acid (10 ml/kg). The numbers 
of writhes (muscular contractions) were counted 20 min post-
injection of acetic acid i. p. The number of writhes in each group was 
compared with the control group and the percent reduction of writhes 
count was calculated as follows: (Ncontrol−Ntest)/Ncontrol ×100, 
where N is the mean number of writhes for each group [25, 26]. 
Anti-nociceptive study  
Two universal models, viz. Eddy’s hot plate and hot water 
immersion assay were performed in rodents. 
Eddy’s Hot plate test 
Pre-screened (showing reaction time of 3-5 sec) Swiss albino female 
mice were divided into 5 groups (n=6). Group 1 received distilled 
water orally and served as control. Group 2 received tramadol (22.8 
mg/kg body weight i. p.) and served as a standard group [12]. Group 
3, 4, and 5 served as test groups and received MEEP (p. o.) at the 
doses 100, 200, and 400 mg/kg body weight, respectively. Eddy’s 
hot plate was maintained at 55±0.5 °C and reaction times (latency 
time for paw licking and jumping responses) were noted at 15, 30, 
60, and 120 min following administration of the drug/extract. Cut off 
time for the experiment was 15 sec [27]. 
Percentage protection against thermal stimulus was calculated by 
the following formula [28]:  
Percentage Protection % =  
Hot water immersion assay 
Wistar rats were divided into 5 groups (n=6). Group 1 received 
distilled water orally and served as control. Group 2 received 
pentazocine (10 mg/kg body weight i. p.) and served as a standard 
group [29]. Group 3, 4, and 5 served as test groups and received 
MEEP at the doses 100, 200, and 400 mg/kg body weight, p. o. 
respectively. Each rat was properly restrained in a rat holder leaving 
the whole tail extending out. The reaction time was determined by 
noting the tail withdrawal response (tail-flick latency) when one-
third of the tail was immersed in a beaker containing water 
maintained at 51±0.5 °C. The cut off time for immersion was 10 sec. 
The reaction time was evaluated at 60 min before and 15, 30, 60, 
and 120 min after the administration of the drug/extract. The idea of 
taking two standard drugs for the models is to compare the efficacy 
of our compound with both of them since both are opioid analgesics. 
Molecular study 
Reverse transcriptase-polymerase chain reaction (RT-PCR) 
The mRNA expression levels of the pro-inflammatory genes (COX-1, 
COX-2, TNF-α, COMT and IL-6) were studied in whole blood using a 
thermocycler (Veriti, Applied Biosystems). Foster City, California, 
United States. The total RNA was isolated from the buffy coat by 
using TRIzol (Ambion) and 1 µg of isolated RNA was reverse 
transcribed to cDNA by using the revert aid first-strand cDNA 
synthesis kit (Thermo Scientific). 'Waltham, Massachusetts, United 
States'. The amplification reaction was carried out in a total volume 
of 10 µl using cDNA, gene-specific primer, nuclease-free water, and 
DreamTaq Green PCR Master Mix (2X). DreamTaq polymerase is 
supplied in 2X DreamTaq Green buffer, along with 0.4 mmol each of 
dATP, dCTP, dGTP and dTTP and 4 mmol MgCl2. The tubes were 
spun for 30 sec before loading into the thermocycler. The cyclic 
conditions include initial denaturation at 95 °C for 3 min, followed 
by 40 cycles each of which 30-sec denaturation at 95 °C, 30-sec 
annealing at 59 °C and 30-sec annealing at 72 °C followed by final 
extension of 10 min at 72 °C. The amplified PCR products were run 
in agarose gel electrophoresis using 2% Agarose containing 
ethidium bromide in 1X TBE buffer to confirm the amplicons. The 
primers used for amplification were adopted from the National 
Centre for Biotechnology Information (NCBI) by Primer-BLAST (ILS 
primers, India). 
Western blotting assay 
Immunoblotting assay of NFκB and IL-10, the serum samples were 
considered as the source of protein. The protein content was 
determined using a Bradford assay. Samples for SDS-PAGE were 
prepared by mixing equal volume of serum and 2X Laemili buffer 
(supplemented by 2-mercaptoethanol (Sigma, MO, USA) in the ratio 
1:100, which was then heated at 90 °C for 5 min. Proteins 
electrophoretically separated on 12% SDS PAGE gels were 
transferred onto a nitrocellulose membrane (Whatman PROTRAN). 
This step was followed by blocking of the membranes using 3% BSA (Hi 
media) in 1X TBST. The membranes were then treated with primary 
antibodies (diluted in 1% BSA in the ratio 1:1000) at 4 °C overnight 
followed by 5 times wash (with 1X TBST) for 5 min each. After this, the 
membranes were probed with secondary antibodies at room 
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temperature and washed with 1X TBST for 5 times. Then TMB (Sigma, 
MO, USA) was applied and the membranes were incubated in dark for 5 
min. The bands were analyzed using Image analyzer (Image J) software. 
Statistical analysis 
Results obtained were expressed as mean±SEM. Statistical analysis 
was conducted by using a one-way analysis of variance (ANOVA) 
followed by Dunnett’s multiple comparison test, using Graph Pad 
Prism software version 5.0 (San Diego, CA, USA). Results were 
considered to be statistically significant when p<0.05. 
Isolation of compounds from Entada phaseoloides 
The methanolic extract (10 gm) of Entada phaseoloides was subjected 
to column chromatography (silica gel, 100-200 mesh, eluting with 
hexane/EtOAc mixture of increasing polarity) for obtaining 40 column 
fractions. Then the column fractions were analyzed with TLC (silica gel 
60 F254, hexane: EtOAc, 60:40), and fractions with similar TLC 
patterns were amalgamated to give five major fractions (F1, F2, F3, F4, 
F5). Fractions F4 was subjected to repeated column chromatography 
eluting with EtOAc: hexane (19:81) to yield compound 1. Fraction F3 
was subjected to Column chromatography (CC) on silica gel (100-200 
mesh) using a hexane-EtOAc (10:0-6:4) to yield subfractions B1 and 
Compound 2. Subfraction B1 was then purified using preparative TLC 
with CHCl3: MeOH (90:10) to obtain compound 3. Repeated 
purification of fraction F3 on silica gel (60-120 mesh) using 
CHCl3/MeOH (12:1) yielded compound 4. 
Oleic acid (1): Light yellow oil, 1H-NMR (500 MHz, CDCl3) d: 5.35 
(2H, m), 2.33(4H, m), 2.01 (4H, m), 1.64 (4H, m), 1.37e1.22 (H, m), 
0.88 (3H, t, J ¼ 7.1 and6.2 Hz).13C NMR (CDCl3, 75 MHz) d: 180.55, 
129.93, 129.63, 34.11, 31.91, 29.76, 29.66, 29.60, 29.53,29.37, 29.32, 
29.14, 29.05, 27.20, 27.13, 24.64, 22.67. HR-ESI-MS m/z: 305.2456 
(Calcd for C18H24O2Na: 305.2451). 
Entadamide A (2): White amorphous powder, 1H-NMR (500 MHz, 
CDCl3) d: 7.62 (1H,d,J¼ 14.5 Hz), 6.44(1H, br s), 5.69(1H, d, J ¼ 14.6 
Hz), 3.71(2H,m), 3.46 (2H, m), 2.32 (3H,s). 13C NMR (CDCl3, 75 MHz) 
d: 165.80, 143.67, 115.31, 62.46, 42.49, 14.60. HR-ESI-MS m/z: 
162.0589 (Calcd for C6H12NO2S: 162.0583). 
Entadamide A-beta-D-glucopyranoside (3): White amorphous powder, 
1H-NMR (500 MHz, CD3OD) d: 2.33 (3H, s), 3.27 (1H, m), 3.29 (1H, m,), 
3.35 (1H, m), 3.37 (1H, m), 3.46 (1H,m), 3.72 (2H, m), 3.90(1H, m), 3.96 
(1H, m), 3.99 (1H, m,), 4.29 (1H, d, J ¼ 7.9 Hz), 5.85 (1H, d, J ¼ 14.58 Hz), 
7.59 (1H, d, J ¼ 14.58 Hz). 13C NMR (75 MHz, CD3OD): d 165.58, 142.31, 
114.83, 102.39, 75.8, 75.67, 72.97, 69.36, 68.23, 60.74, 38.92, 13.4. HR-
ESI-MS m/z: 346.0946 (Calcd for C12H21NO7S: 346.0931). 
Phaeoloidin (4): White amorphous powder, 1H-NMR (DMSO-d6, 500 
MHz) δ: 9.00(1H, s, 4-OH), 6.94 (1H, d, J = 8.6 Hz, H-3), 6.58 (2H, m, H-5, 
H-6),4.99 (2H, brs, H-7), 4.53 (1H, d, J=7.4 Hz), 3.68 (dd, J = 11.8, 1.9 Hz, 
1H), 3.61 (1H,d, J =15.7)&3.51(1H,d,J=15.7),3.46 (dd, J = 11.8, 5.6 Hz, 
1H),3.20 (td, J = 5.7, 3.2 Hz, 4H), 3.14 (1H,dd, J= 7.4&8.5). 13C-
NMR(DMSO-d6, 300 MHz)δ: 172.92 (C-8), 152.02 (C-4), 148.51(C-1), 
125.88 (C-2), 117.45 (C-6), 117.03 (C-3), 113.97(C-5), 102.91 (C-1’), 
76.90 (C-5’), 76.49 (C-2’), 73.38 (C-3’), 69.74 (C-4’), 60.80 (C-6’), 34.93 
(C-7). HRMS (ESI+) m/z: 329.0875 ([M-H]-;C14H18O9 calcd. 329.0873). 
RESULTS 
Acute toxicity study 
No mortality or significant changes in behavior and body weight 
was observed following oral administration of MEEP at 2000 
mg/kg. Accordingly 100, 200, and 400 mg/kg, p. o. were used in 
the study.  
Pure compound isolated from Entada phaseoloides 
Subjecting of MEEP to fractionation and purification led to the 
isolation of 4 compounds. The structures of isolated compounds 
were known by using IR, MS, 1D, and 2D NMR spectroscopic 
techniques. A comparison of the spectral data with those reported in 
the literature [30] led to identification and confirmation of the 
compounds as Oleic acid (1), Entadamide A (2), Entadamide A-b-D-
glucopyranoside (3) and Phaseoloidin. 
 
 
Fig. 1: Structures of pure compounds isolated from Entada 
phaseoloides 
 
Peripheral analgesic activity study 
Acetic acid-induced writhing in mice 
Results of the acetic acid-induced writhing test revealed that MEEP 
significantly reduces the writhes count as compared to the control 
group (fig. 2). Diclofenac sodium, the standard drug, showed the 
highest protection against acetic acid-induced writhing (76.8%). The 
analgesic activity shown by MEEP against peripherally induced 
analgesia was dose-dependent, producing the highest analgesic 
activity at 400 mg/kg with percent protection of 58.1% against the 
peripherally induced sensation of pain. Hence, its effect on peripheral 
analgesia as compared to diclofenac sodium is not profound. 
Effect of MEEP on Eddy’s hot plate test in mice 
The results of the analgesic activity of MEEP using the hot plate 
method are presented in table 1. The latency times were recorded at 
15, 30, 60, and 120 min post administration of the drug/extract. The 
percentage protection offered by the standard drug (tramadol) was 
the highest (96.20) at 2 h following drug administration, whereas, 
the percent protection offered by MEEP at the dose rate of 400 
mg/kg body weight was 54.52, following 1 h of drug administration. 
However, at 1 h, the percent protection provided by 400 mg/kg 
body weight of MEEP (54.52) was higher than that of tramadol 
(52.01). The effect of tramadol lasted until 2 h. 
 
Table 1: Analgesic activity of MEEP on Eddy’s hot plate in mice 
Groups Treatment Response mean±SEM (s) (Percent inhibition) 
15 min 30 min 60 min 120 min 
1. Control 2.9±0.17 3.7±0.16 3.98±0.20 3.95±0.23 
2. Tramadol (22.8 mg/kg, i. p.) 4.1±0.18* (41.37 %) 5.08±0.17* (37.2 %) 6.05±0.20* (52.01 %) 7.75±0.27* (96.20 %) 
3. MEEP (100 mg/kg, p. o.) 4.2±0.23 (44.82 %) 4.7±0.22 (27.02 %) 4.4±0.10 (41.37 %) 5.1±0.23 (10.5 %) 
4. MEEP (200 mg/kg, p. o.) 3.9±0.32 (34.4 %) 4.8±0.24 (29.72 %) 4.5±0.21 (13.06 %) 5.7±0.36 (44.30 %) 
 5. MEEP (400 mg/kg, p. o.) 4.7±0.26 (62.06 %) 4.6±0.17 (24.32 %) 6.15±0.61 (54.52 %) 5.9±0.31 (49.3 %) 
*Values represent mean ± SEM of n=6, *p < 0.05,**p < 0.01, ***p < 0.001, compared to control (one-way ANOVA followed by "Dunnett's Multiple 
Comparison Test") 
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Hot water immersion induced analgesia in rats 
The results of the analgesic activity of MEEP as assayed with hot 
water immersion are presented in table 2. There was a significant 
difference between the vehicle (negative control) and test groups 
on the thermal stimulus in rats throughout the whole duration of 
the experiment. Significant (p<0.05) analgesic activity of the 
standard drug, pentazocine, at 15, 30, 60, and 120 min, as 
compared to the control animals was observed. Also, with respect 
to the control group, it was found significant in groups 3, 4, and 5. 
Pentazocine significantly increased the response time of the 
animal to 7.2 sec (after 120 min), and showed a significant 
increase in the latency time of rats when compared with the 
control group. As can be seen in table 2, there was a significant 
increase in latency time of MEEP in 100, 200, and 400 mg/kg, p. o. 
at 15, 30, 60, and 120 min; however, the maximum activity was 
recorded at 120 min. The percent protection offered by MEEP at 
400 mg/kg body weight is at par with that of pentazocine at the 



































Fig. 2: Analgesic effects of the MEEP and diclofenac sodium on the acetic-acid-induced writhing response in mice. Each value represents as 
mean ± SEM. ***p < 0 .001 as compared with the control group (one-way ANOVA followed by "Dunnett's Multiple Comparison Test" 
 
Table 2: Analgesic activity of MEEP and pentazocine in rats assayed using hot water immersion method 
Groups Treatment (mg/kg) Response mean±SEM (s) (percent protection) 
Before After 
60 min 15 min 30 min 60 min 120 min 
1. Control 2.8±0.35 2.4±0.22 2.6±0.13 2.7±0.097 2.9±0.26 
2. Pentazocine (10 mg/kg i. 
p.) 
2.36±0.22 4.1±0.40* (70.8 %) 3.87±0.34* (48.84 
%) 
5.2±0.43* (92.5 %) 7.2±0.11* (148.27 
%) 
3. MEEP (100 mg/kg, p. o.) 2.8±0.26 4.2±0.23* (75 %) 4.8±0.22* (84.61 %) 4.6±0.10* (70.37 %) 5.3±0.23* (82.75%) 
4. MEEP (200 mg/kg, p. o.) 2.8±0.28 4.6±0.32* (91.66 %) 3.6±0.24* (41.53 %) 5.02±0.21* (85.92 
%) 
5.7±0.35* (97.2 %) 




5.07±0.09* (87.7 %) 6.58±0.11* (126.89 
%) 
*(Numbers in parenthesis indicate percentage increase in reaction time when compared with control. *p<0.05 when compared with control, n=6) 
(one-way ANOVA followed by "Dunnett's Multiple Comparison Test") 
 
Effects of MEEP on gene expressions of COX-1, COX-2, COMT, IL-
6 and TNF-α at 60 and 120 min time intervals respectively by 
Reverse transcriptase PCR (RT-PCR) 
The Reverse Transcriptase-PCR analysis of gene expression on 
COMT, COX-1, COX-2, IL-6, and TNF-α at 60 and 120 min time 
intervals is presented in fig. 3. The mRNA expression levels of 
COMT at 60 and 120 (p<0.001) min were significantly up-
regulated in the MEEP treated rats as compared to the vehicle 
control group. COX-1 enzyme demonstrated no significant 
difference between the groups. However, mRNA expression levels 
of COX-2 at 60 and 120 (p<0.001) min were significantly down-
regulated in the MEEP treated rats as compared to the vehicle 
control group. The mRNA expression levels of IL-6 at 60 and 120 
(p<0.001) min were down-regulated in the MEEP treated rats as 
compared to the vehicle control group; the down-regulation of 
mRNA expression levels of TNF-α at 60 and 120 (p<0.001) min 
could also be seen in the MEEP treated rats compared to the 
vehicle control group. The mRNA expression levels of IL-6 at 60 
and 120 (p<0.001) min and TNF-α at 60 and 120 (p<0.001) min 
were almost similar in the tramadol treated rats compared to the 
vehicle control group. 
Immunoblotting assay of NFκB and IL-10 at 60 and 120 min in 
rats treated with MEEP 
Protein expressions in the serum of control as well as test groups, 
were assayed by western blotting. The results of the test groups as 
well as a standard drug (pentazocine) were compared with the 
control group. The results elucidated that there was down-
regulation of NFκB and up-regulation of protein levels of IL-10 in the 
MEEP treated groups when compared with the control group. Dose 
and time-dependent significant down-regulation were observed in 
the protein levels of NFκB at 60 and 120 min (p<0.001) following 
extract administration. At 120 min time interval, there was 
significant down-regulation of the targeted NFκB gene, while protein 
expressions of IL-10 were significantly up-regulated in 400 mg/kg 
body weight treated rats when compared to the control (fig. 4). 
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Fig. 3: Quantitative data expression of mRNA of COMT (60 min, 120 min), COX-1 (60 and 120 min), COX-2 (60 and 120 min), IL-6 (60 and 
120 min), TNF-α (60 and 120 min) as fold change as compared with vehicle control group. Values are expressed as mean±SEM (*p<0.05, 
**p<0.01, ***p<0.001) compared with vehicle control group. Lane1 = Control, Lane2 = Tramadol, Lane3 = MEEP 100 mg/kg, Lane4 = MEEP 
200 mg/kg, Lane5 = MEEP 400 mg/kg 
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Fig. 4: Quantitative data expression of proteins levels (A) NFκB at 60 min, (B) NFκB at 120 min (C) IL-10 at 60 min and (D) IL-10,120 min. 
Values are expressed as percent fold change compared with control. Values represented as mean±SEM (n=6). *p<0.05, **p<0.01, 
***p<0.001 compared with control group. Lane1= Protein Ladder, Lane2 = Control, Lane3 = Pentazocine 100 mg, Lane4 = MEEP 100 
mg/kg, Lane5= MEEP 200 mg/kg, Lane6= MEEP 400 mg/kg 
 
DISCUSSION 
Pain, a component firmly bonded with a multitude of clinical 
pathologies requires skillful and adequate management. There is a 
need to develop newer powerful analgesic agents with minimum 
side effects from natural sources [31]. Current therapies are vested 
with many side effects and thus have made researchers take an 
interest in hunting new products, and more particularly, herbal-
based products. Entada phaseoloides, a plant that plentifully covers 
the cultivation of Himalayan belt and Arunachal Pradesh in 
particular, is gaining importance owing to its folklore and traditional 
medicinal properties. The current study was undertaken to explore 
the underlying mechanism of the analgesic activity of this plant, 
which is used traditionally to cure pain and inflammation for ages. 
From the acute toxicity study, it is apparent that MEEP did not 
produce any toxicity at 2000 mg/kg body weight and thus 
considered safe. The antinociceptive activity of new drugs can be 
verified by assessing their effects centrally or peripherally, where 
the hot plate test used to evaluate the centrally acting analgesic 
effect and the acetic acid-induced writhing test used to evaluate the 
peripheral acting analgesic effect [32]. MEEP was tested for its 
ability to minimize or eliminate peripherally induced pain. A 
writhing test is a reliable method to assess the peripheral analgesic 
activity of any compound. It is a chemical method very often used for 
inducing pain of peripheral origin by using irritant principles like 
phenylquinone or acetic acid in female mice [33,34]. Plants that are 
effective in the writhing test have peripheral anti-nociceptive 
activity [35]. Our study noticeably showed the analgesic activity of 
MEEP against peripherally induced pain was dose-dependent and 
maximum analgesic activity was seen at 400 mg/kg with percent 
protection of 58.1%. Eddy’s hot plate and hot water immersion test 
are two frequently used standard pharmacological models for 
investigating central analgesic activity [36-38]. The results of Eddy’s 
hot plate has made it obvious that MEEP exhibited anti-nociceptive 
activity by increasing the latency time of responses in mice in all 
tested doses following 60 and 120 min of administration. The 
percentage protection offered by MEEP at 400 mg/kg body weight is 
at par with that of tramadol following 1h of drug administration. In 
comparison to control, tramadol produced the highest analgesic 
activity among all tested samples whose peak activity was reached 
after 2 h.  
The hot water immersion assay revealed that MEEP produced 
significant anti-nociceptive activity in a dose-dependent manner by 
increasing the latency time of responses in rats [39]. Among tested 
doses, 400 mg/kg exhibited more anti-nociceptive activity, and the 
potency was maximal at 2 h. In comparison to control, pentazocine 
produced the highest analgesic activity among all tested samples. 
The data from Eddy’s hot plate test as well as the hot water 
immersion assay emphasized that MEEP showed a dose and time-
dependent analgesic activity as compared to the control group. 
There might be some components in the MEEP that act centrally via 
the activation of opioid receptors [40]. The analgesic activity of 
MEEP could be due to its constituents like oleic acid [41] or 
entadamide [42] or both. We have taken two standard drugs 
tramadol and pentazocine in the eddy’s hot plate and hot water 
immersion model, respectively, to compare the efficacy with MEEP. 
To further assess the antinociceptive and anti-inflammatory 
mechanisms of Entada phaseoloides, we conducted the molecular 
analysis. Under oxidative stress, ROS may initiate and exaggerate the 
inflammatory responses due to their capability to stimulate and 
regulate the inflammatory signaling cascades genes like NFκB and 
pro-inflammatory cytokines [43, 44]. The transcription factor NFκB 
plays a crucial role in regulating the expression of two significant 
anti-inflammatory factors, COX-2, and dynorphin that play dynamic 
role in augmenting the responses caused by nociceptive stimuli. 
COX-2, a major contributor to the synthesis of prostaglandin E2 
brings about all the changes that happen to occur during 
inflammation, and thus induces the troubling sensation called ‘pain’ 
[45]. IL-10 is a potent anti-inflammatory cytokine housed in 
monocytes, macrophages, Th2, and B cells [46]. It inhibits NFκB 
activity [47] and promotes the degradation of mRNAs of pro-
inflammatory cytokines [48]. In our study, as observed from the 
immunoblotting analysis, MEEP treated rats showed significant 
down-regulation of NFκB, whereas expression of the anti-
inflammatory cytokine, IL-10 was significantly upregulated. 
COMT is the key enzyme involved in the metabolism of the 
catecholamines: noradrenaline, adrenaline, and dopamine. COMT, an 
enzyme responsible for the regulation of pain perception, cognitive 
function, and mood, is an important regulator of catecholamine 
concentrations in the perception of pain [49, 50]. Lower COMT is 
associated with hyperalgesia brought about by stimulation of β2-
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adrenergic receptors by catecholamines [51, 52]. Our study elucidated 
that there was significant up-regulation of the COMT gene at mRNA 
levels suggesting its crucial role being played in managing pain. 
Cyclooxygenase enzymes play a pivotal role in prostaglandin synthesis 
that brings about the cascades of changes that take place during 
inflammation. It has two isotypes viz. COX-1 and COX-2. COX-1 is 
present throughout the body and plays a crucial role in regulating 
normal physiological functions of the body [53]. Blocking of this 
isotype can cause gastrointestinal side-effects. On the contrary, the 
expression of COX-2 gears up in the brain [54] and kidney [55] during 
basal conditions. Inflammation induces COX-2 and causes increased 
release of prostanoids culminating in peripheral nociception [56, 57]. 
Peripheral inflammation also induces pain in the neighboring 
uninjured tissue due to increased neuronal excitability [58]. Thus 
increased COX-2 activity is tightly bonded with sensation of pain. COX-
1 is constitutively active throughout the body and its activity 
predominates during normal physiological conditions [53]. In contrast, 
COX-2 expresses under basal conditions in the brain and kidney [53, 
55]; however, it is markedly upregulated by a variety of inflammatory 
mediators. Because there is an induction of COX-2 at sites of 
inflammation, it’s believed that the therapeutic properties of NSAIDs 
account primarily for the inhibition of COX-2 [54, 59]. It was reported 
that no change in expression of COX-1 in normal rat paws compared to 
inflamed ones [60] and our study also visibly illustrated that MEEP 
causes significant down-regulation of COX-2. 
Cytokines play a vital role in coordinating the immune system and the 
inflammatory response. Cytokines may be broadly classified as pro-
inflammatory, (TNFα, IL-6, IL-8) or anti-inflammatory (IL-10, IL-4, and 
TGFβ) [61]. In our study, mRNA levels of IL-6 and TNF-α were 
significantly down-regulated. Hence pain perception in treated groups 
including MEEP and the standard group was reduced. On the other hand, 
anti-inflammatory cytokine IL-10 and COMT were increased. 
The present study throws light on the fact that the MEEP has got 
central and weak peripheral analgesic activity. It also exemplified 
that the anti-nociceptive or anti-inflammatory activity occur 
following administration of MEEP might be either due to the down-
regulation of some pro-inflammatory genes like NFκB, IL-6, and 
TNF-α or up-regulation of anti-inflammatory factors like IL-10 and 
the enzyme COMT. 
CONCLUSION 
As expected, our study showed analgesic activity of MEEP in 
experimental models of nociception at 400 mg/kg. MEEP possesses 
weak peripheral and potent central analgesic properties. It may be 
due to constituents like entadamide or oleic acid or both might 
contribute its analgesic property. The mechanism by which it brings 
about analgesia could be due to the up-regulation of anti-
inflammatory factors like IL-10, COMT, or down-regulation of pro-
inflammatory factors like COX-2, NFκB, IL-6, and TNF-α. The study 
corroborated the analgesic effects of this species, justified and 
supported its ethnopharmacological use scientifically as an analgesic 
and anti-inflammatory agent to treat pain and inflammation. 
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